Clinical phase i trial of a new anti-neoplastic drug--glyciphosphoramide
Sun, Y.
Zhonghua Zhong Liu Za Zhi 6(4): 293-295
1984
ISSN/ISBN: 0253-3766 PMID: 6525950 Document Number: 239136
Document emailed within 1 workday
Related Documents
Sun, Y. 1984: Clinical phase Ii trial of a new antineoplastic drug, glyciphosphoramide (GPM) Zhonghua Zhong Liu Za Zhi 6(5): 375-378Abate, G.; Cuccurullo, F.; Curti, A. 1973: Clinical trial of a new anti-anginal drug: 2-benzofuryl-p-chlorophenyl carbinol (clobenfurol) Minerva Cardioangiologica 21(2): 145-153
Huang, X-dong.; Yi, J-lin.; Gao, L.; Xu, G-zhen.; Jin, J.; Yang, W-zhi.; Lu, T-xiang.; Wu, S-xiong.; Wu, R-rui.; Hu, W-han.; Xie, W-chang.; Han, F.; Gao, Y-hong.; Gao, J-ming.; Pan, J-ji.; Chen, C-ben.; Lang, J-yi.; Li, T.; Dong, Y.; Fu, Y-bing.; Fan, L.; Li, B-sen.; Li, J.; Wang, X-huai.; Chen, B-xu.; Gao, X-shu.; Zhang, P.; Wu, X-wei.; Hu, B-qiang. 2007: Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma Zhonghua Zhong Liu Za Zhi 29(3): 197-201
Galler, A.S.; Bauer, T.L. 2009: A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) Yearbook of Oncology 2009: 194-195
Teehan, M. 1994: Guidelines for phase IV clinical trials. Joint Committee on Phase IV Clinical Trial Guidelines Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 39(10): 629-633
Katayose, Y.; Yamamoto, K.; Nakagawal, K.; Takemura, S.; Takahashi, M.; Nakamura, R.; Shimamura, H.; Rikiyama, T.; Egawa, S.; Yoshda, H.; Motoi, F.; Naitoh, T.; Unno, M. 2015: Feasibility Assessment of Modified FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001) Hepato-Gastroenterology 62(138): 303-308
Stock, P.G.; Lantz, M.; Light, S.; Vincenti, F. 1996: In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients Transplantation Proceedings 28(2): 915-916
Pitisuttithum, P.; Choopanya, K.; Bussaratid, V.; Vanichseni, S.; van Griensven, F.; Phonrat, B.; Martin, M.; Vimutsunthorn, E.; Sangkum, U.; Kitayaporn, D.; Tappero, J.W.; Heyward, W.; Francis, D. 2007: Social harms in injecting drug users participating in the first phase IIi HIV vaccine trial in Thailand Journal of the Medical Association of Thailand 90(11): 2442-2448
Furue, H.; Kako, M.; Mugitani, H.; Fuse, K.; Hirota, F.; Sakamoto, K.; Takahashi, T.; Ezaki, M.; Yamada, K.; Suminaga, M.; Kaise, R. 1983: Phase Ii clinical trial of MCNU Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(7): 1679-1683
Marshall, L.L.; Frye, R.F.; Murphy, J.E. 1990: Students' experience in a phase IIi clinical trial American Journal of Hospital Pharmacy 47(5): 1014; 1016
Breneman, D.; Sheth, P.; Berger, V.; Naini, V.; Stevens, V. 2007: Phase Ii clinical trial of bexarotene gel 1% in psoriasis Journal of Drugs in Dermatology: Jdd 6(5): 501-506
Guha, S.K.; Singh, G.; Anand, S.; Ansari, S.; Kumar, S.; Koul, V. 1993: Phase I clinical trial of an injectable contraceptive for the male Contraception 48(4): 367-375
Marino, L.; Baroni, G.; Riccardi, A.; Franchi, M. 1982: Controlled trial of a prostaglandin-inhibiting, non-steroid, anti-inflammatory drug in primary dysmenorrhea Minerva Ginecologica 34(10): 791-796
Korman, D.B.; Mikaélian, S.G.; Boronovskaia, L.E.; Maslova, I.A. 2004: Results of a phase I-Ii clinical trial of Emoxyl, a novel antineoplastic anthracycline Voprosy Onkologii 50(2): 202-207
Portolés Pérez, A. 1999: Phase i clinical trial units in Spain: the current situation Methods and Findings in Experimental and Clinical Pharmacology 21 Suppl B: 33-35
Van Echo, D.A.; Egorin, M.J.; Whitacre, M.Y.; Olman, E.A.; Aisner, J. 1984: Phase I clinical and pharmacologic trial of carboplatin daily for 5 days Cancer Treatment Reports 68(9): 1103-1114
Guha, S.K.; Singh, G.; Ansari, S.; Kumar, S.; Srivastava, A.; Koul, V.; Das, H.C.; Malhotra, R.L.; Das, S.K. 1997: Phase II clinical trial of a vas deferens injectable contraceptive for the male Contraception 56(4): 245-250
Creagan, E.T.; Schutt, A.J.; Ingle, J.N.; O'Fallon, J.R. 1983: Phase Ii clinical trial of L-alanosine in advanced upper aerodigestive cancer Cancer Treatment Reports 67(11): 1047
Spiegel, R.J.; Blum, R.H.; Levin, M.; Pinto, C.A.; Wernz, J.C.; Speyer, J.L.; Hoffman, K.S.; Muggia, F.M. 1982: Phase i clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule Cancer Research 42(1): 354-358
Lyu, Q.; Xu, J. 2015: Consideration on the design of early phase clinical trial of new anticancer drugs Zhonghua Zhong Liu Za Zhi 37(3): 235-240